Page last updated: 2024-08-24

triazoles and 5-(4-amino-1-propan-2-yl-3-pyrazolo[3,4-d]pyrimidinyl)-1,3-benzoxazol-2-amine

triazoles has been researched along with 5-(4-amino-1-propan-2-yl-3-pyrazolo[3,4-d]pyrimidinyl)-1,3-benzoxazol-2-amine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Fang, B; Gao, L; Kannan, A; Kannan, K; Lin, Z; Moreno, MA; Shao, Q; Stack, BC; Suen, JY; Vural, E; Zhao, S1
Ding, X; Gao, L; Liu, Z; Sun, Y; Wu, Q; Zeng, T1
Belcheva, A; Boone, T; Chang, JCN; Cohen, AL; Darcourt, JG; Ensor, J; Hemati, P; Kaklamani, VG; Koca, E; Li, X; Murthy, A; Nair, S; Niravath, PA; Patel, TA; Qian, W; Ramshesh, PV; Wong, H; Zhao, J1

Trials

1 trial(s) available for triazoles and 5-(4-amino-1-propan-2-yl-3-pyrazolo[3,4-d]pyrimidinyl)-1,3-benzoxazol-2-amine

ArticleYear
ANETT: PhAse II trial of NEoadjuvant TAK-228 plus Tamoxifen in patients with hormone receptor-positive breast cancer.
    Breast cancer research and treatment, 2021, Volume: 188, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Benzoxazoles; Breast Neoplasms; Female; Hormones; Humans; Neoadjuvant Therapy; Nitriles; Pyrimidines; Receptor, ErbB-2; Receptors, Estrogen; Tamoxifen; Treatment Outcome; Triazoles

2021

Other Studies

2 other study(ies) available for triazoles and 5-(4-amino-1-propan-2-yl-3-pyrazolo[3,4-d]pyrimidinyl)-1,3-benzoxazol-2-amine

ArticleYear
Dual mTOR inhibitor MLN0128 suppresses Merkel cell carcinoma (MCC) xenograft tumor growth.
    Oncotarget, 2016, Feb-09, Volume: 7, Issue:6

    Topics: Animals; Apoptosis; Azepines; Benzoxazoles; Blotting, Western; Carcinoma, Merkel Cell; Cell Proliferation; Cellular Senescence; Drug Synergism; Drug Therapy, Combination; Female; Humans; Immunoenzyme Techniques; Mice; Mice, Inbred NOD; Mice, SCID; Pyrimidines; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Skin Neoplasms; TOR Serine-Threonine Kinases; Triazoles; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2016
In Vitro Interactions between Target of Rapamycin Kinase Inhibitor and Antifungal Agents against Aspergillus Species.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Benzoxazoles; Caspofungin; Drug Combinations; Drug Synergism; Echinocandins; Fungal Proteins; Gene Expression; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; TOR Serine-Threonine Kinases; Triazoles; Voriconazole

2016